跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DICLOFENAC SODIUM SOLUTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DICLOFENAC SODIUM SOLUTION
Authorized
STANDARD
DICLOFENAC SODIUM SOLUTION
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9b0f2517b22f6b95
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
9b0f2517b22f6b95
Drug Approval Canada Name
DICLOFENAC SODIUM SOLUTION
Product Name
DICLOFENAC SODIUM SOLUTION
Status
Dormant
Status Date
2022-09-29
Original Market Date
2018-08-22
Din
02476134
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Topical
Schedule
Prescription
Ahfs
28:08.04.92
Atc Original
M02AA15 DICLOFENAC
Atc Name
m 02 aa 15
Aig Number
0114417007
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
DICLOFENAC SODIUM
1.5 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9b0f2517b22f6b95
Type
Standard
Back to Health Canada Approvals